Models for predicting the risk of cardiovascular (CV) events based on individual patient characteristics are important tools for managing patient care. Most current and commonly used risk prediction models have been built from carefully selected epidemiological cohorts. However, the homogeneity and limited size of such cohorts restrict the predictive power and generalizability of these risk models to other populations. Electronic health data (EHD) from large health care systems provide access to data on large, heterogeneous, and contemporaneous patient populations. The unique features and challenges of EHD, including missing risk factor information, non-linear relationships between risk factors and CV event outcomes, and differing effects from different patient subgroups, demand novel machine learning approaches to risk model development. In this paper, we present a machine learning approach based on Bayesian networks trained on EHD to predict the probability of having a CV event within 5 years. In such data, event status may be unknown for some individuals, as the event time is right-censored due to disenrollment and incomplete follow-up. Since many traditional data mining methods are not well-suited for such data, we describe how to modify both Responsible editors: Ē are analogous to the quantities in (24), but correspond to expected number of subjects in each category, with the expectations computed using the Kaplan-Meier estimator to account for censoring. As with the usual NRI, a positive cNRI(M 1 , M 2 ) means better reclassification performance for model M 1 , while a negative cNRI(M 1 , M 2 ) favors model M 2 .
modeling and assessment techniques to account for censored observation times. We show that our approach can lead to better predictive performance than the Cox proportional hazards model (i.e., a regression-based approach commonly used for censored, time-to-event data) or a Bayesian network with ad hoc approaches to right-censoring. Our techniques are motivated by and illustrated on data from a large US Midwestern health care system.
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In the United States, myocardial infarctions (MI) and strokes are the first and fourth leading causes of death, and, in addition to contributing significantly to mortality, these conditions account for substantial morbidity with treatment costing more than $300 billion annually (Go et al. 2014) . Clinical risk prediction scores or algorithms remain important tools for managing patient care and improving outcomes in the population. Broadly speaking, risk prediction scores can raise awareness of the substantial burden of cardiovascular disease (CVD) and risk factors associated with developing CVD (Lloyd-Jones 2010). In the clinical setting, accurate personalized cardiovascular (CV) risk prediction may identify patients at high risk for experiencing CV events (e.g., MI, stroke) so that clinicians may develop an appropriate intervention strategy and patients are motivated to remain adherent to that strategy.
Recent systematic reviews found that there are over 100 risk models produced between 1999 and 2009 (Cooney et al. 2009 (Cooney et al. , 2010 Matheny et al. 2011) including the well-known Framingham , SCORE (Conroy et al. 2003) , ASSIGN-SCORE (Woodward et al. 2007 ), QRISK1 (Hippisley-Cox et al. 2007 , 2008a , QRISK2 (Hippisley- Cox et al. 2008b ), PROCAM (Assmann et al. 2002) , WHO/ISH, and Reynolds Risk Score (Ridker et al. 2007 (Ridker et al. , 2008 . Although there are many risk prediction models for CVD, nearly all have been estimated using data from carefully selected epidemiological cohorts. For example, the Framingham risk score is trained on a data set that excludes patients that have had a previous CV event, represents a predominantly Caucasian population, and includes patients from the late 1960s . As a result of estimating the risk of CV events using data from these homogeneous cohorts, existing risk models are likely to only give accurate predictions for patients who are well represented in the training data sets. Collins and Altman (2009) provide an excellent illustration of the poor performance of the Framingham risk equations when applied to a contemporary population in the United Kingdom. Models constructed from a more diverse cohort are likely to produce more accurate estimates of CV risk for a wider range of patients seen in the primary care clinic.
One source of clinical data is electronic health data (EHD) collected by a health maintenance organization (HMO). These data consist of electronic medical records (EMRs), insurance claims data, and mortality data obtained from the state government.
EHD are increasingly available within the context of large health care systems and capture the characteristics of a heterogeneous population receiving care in a contemporary clinical setting. EHD databases typically include records on hundreds of thousands to millions of individual patients; therefore, a risk prediction model constructed from EHD could yield more accurate and generalizable risk predictions because even relatively specific sub-populations (e.g., patients with multiple comorbidities) are likely to be well-represented in such a large database.
Challenges of electronic health data
Although the scale and complexity of EHD provide great opportunities to improve CV risk prediction for contemporary patient populations, these data also pose serious challenges to those seeking to mine it, especially in comparison to data collected from epidemiological cohorts. Here, we briefly describe some of these challenges, all of which are present in the data set we describe in Sect. 3.
Missing data
Electronic medical record data are purely observational in the sense that they record individuals' encounters with the health care system, however regular or irregular those encounters may be. Without a structured schedule for clinic visits, laboratory measurements may be obtained sporadically or simply be unavailable. Further, even when individuals do make regular clinical visits, clinical practice guidelines may recommend against obtaining certain measurements within particularly low-risk populations. For instance, it is uncommon for individuals under the age of 40 to obtain cholesterol measurements as part of a routine checkup. Several statistical techniques exist for imputing missing data, but the scale and complexity of EMR data make many of these unappealing.
Subgroup heterogeneity
Electronic health data comprehensively describe diverse, contemporaneous patient populations. In contrast to a cohort study, patients do not have to satisfy eligibility criteria to appear in the database. Though in some cases it may make sense to restrict an EHD-based study to a narrowly defined sub-population (e.g., individuals with diabetes), our goal is to develop methods which make maximal use of the available data. Hence, the advanced risk prediction methods should be capable of using the data to automatically identify non-linear relationships between risk factors and CV events as well as sub-populations where the effects of those factors differ.
Sample size
The enormous sample size afforded by EHD is simultaneously a blessing and a curse. While there are ample data to support flexible nonparametric risk models, the complexity of these models is restricted by the ability to train them on hundreds of thousands or millions of records in a reasonable amount of time.
Incomplete follow-up and censoring
Our motivating data set is drawn from 10 years of EHD derived from an HMO. However, not all subjects were enrolled in the HMO for the full 10-year period, either because their first enrollment came after the beginning of this period or because they terminated insurance coverage (e.g., due to a change in employer) during the period. In this paper, we seek to estimate the 5-year risk of CV events. But the occurrence of CV events is not recorded in the EMR or in claims data during times when subjects are not enrolled, and a substantial fraction of subjects (71 % in our data) do not have enough follow-up data in the EMR to ascertain if they experienced a CV event over a 5-year period. In the language of statistical survival analysis, such subjects are said to be right-censored.
The standard statistical methods to model the relationship between risk factors and time-to-event outcomes are the Cox proportional hazards model (Cox 1972 ) and, to a lesser extent, the accelerated failure time model (Buckley and James 1979) . Although these methods handle censored outcomes, they do not natively address the first three challenges encountered in EHD. In particular, the proportional hazards model assumes that the risk factors have a linear relationship with the log hazard of experiencing a CV event. If the analyst has a priori knowledge that this relationship is non-linear or differs in certain sub-groups, she may include non-linear transformations of predictors or interactions between predictors, but this is often based on trial and error. Secondly, standard software for proportional hazards models removes subjects with any missing features which is a large percentage for EHD, and, as noted above, imputation methods may be onerous given the scale and complexity of EHD. Finally, as noted by Kattan et al. (1998) , the proportional hazards model will show improved fit when additional terms are added in the model, and there is no reliable indication when the model has been overfit.
The first three challenges (missing data, subgroup heterogeneity, and data dimensionality) motivate the use of a sophisticated, flexible, and scalable machine learning technique such as a Bayesian network to mine EHD. However, the fourth challenge (incomplete follow-up) is not directly addressed by usual machine learning approaches. In the next section, we discuss the implications of censoring on the application of machine learning techniques.
Machine learning with censored outcome data
Many data mining techniques have been developed for the related tasks of classification and class probability estimation for a binary outcome. These methods have been shown to yield a performance that is superior to traditional regression-based techniques in healthcare-related classification problems (Song et al. 2004; Colombet et al. 2000) , and are more adept at handling the aforementioned challenges of EHD. However, they are not designed for use in circumstances where outcomes may be censored.
Fully supervised machine learning methods assume that the outcome is known for all subjects, but in our setting the binary outcome (whether or not a patient experiences a CV event within 5 years) is undetermined for subjects who are censored, i.e., who do not experience an event but do not have a full 5 years of follow-up. Simplistic techniques to deal with this issue, such as discarding censored observations (see, e.g., Larranaga et al. 1997; Sierra and Larranaga 1998; Blanco et al. 2005) or treating them as zeroes (non-events), are known to induce bias in the estimation of class probabilities (Kattan et al. 1998) , making typical fully supervised classification approaches unsuitable. For example, Stajduhar et al. (2009) demonstrated the impact of unaccounted-for censoring on the construction and performance of Bayesian networks. Semi-supervised approaches are also generally not applicable since the labeled (non-censored) and unlabeled (censored) observations are not samples from the same underlying population. Furthermore, censored observations are not truly 'unlabeled' since they carry useful partial information about the outcome (i.e., that the event outcome did not occur before the subject was censored).
There has been an increasing interest to adapt machine learning techniques to this type of censored, time-to-event data (Lucas et al. 2004) . As one example, Ishwaran et al. (2008) make use of specialized random survival forests to analyze right-censored survival data, where a survival score is associated with every terminal node of the trees in the forest. Inspired by the growing need and opportunities for machine learning approaches to complex healthcare data-driven problems, we propose a generalpurpose extension of Bayesian networks using inverse probability of censoring weights (IPCW). The resulting technique properly accounts for censoring while retaining the features which make this flexible machine learning approach appealing in the context of EHD. We also show that traditional evaluation metrics for classification accuracy (e.g., receiver-operating curve, net reclassification improvement) may be misleading in the presence of censoring, and describe better alternatives.
Bayesian networks for electronic health data

Why Bayesian networks?
Bayesian networks are especially well-suited to handle the intricacies of risk prediction using EHD. Compared to support vector machines or neural networks, Bayesian networks have a clear edge in interpretability, which is important to the end-users of these prediction models in the healthcare domain (e.g., physicians and clinical researchers). The Bayesian network framework we adopt is computationally efficient and handles missing data naturally and efficiently, eliminating the need for EHD sets to be "pre-imputed" to produce complete data.
Because of their interpretability and their ability to aid in reasoning with uncertainty, Bayesian networks have been used extensively in biomedical applications (see Lucas et al. 2004 for a review). In particular, they have been: used to aid in understanding of disease prognosis and clinical prediction (Andreassen et al. 1999; Verduijn et al. 2007; Lipsky and Lewis 2005; Sarkar and Koehler 2013; Vila-Frances et al. 2013; Lappenschaar et al. 2013 ); used to guide the selection of the appropriate treatment (Lucas et al. 2000; Kazmierska and Malicki 2008; Smith et al. 2009; Yet et al. 2013; Velikova et al. 2014) ; and implemented as part of clinical decision support systems (Lucas et al. 1998; Sesen et al. 2013) .
In spite of the wide applicability in biomedical applications, there is a limited amount of previous work on the application of Bayesian networks to censored outcome data (Lucas et al. 2004 ). Zupan et al. (1999) and Stajduhar and Dalbelo-Basic (2010) have proposed approaches in which censored observations are repeated twice in the dataset, one as experiencing the event and one event-free. Each of these observations are assigned a weight based on the marginal probability of experiencing an event between the censoring time and τ , the time the event status will be assessed. This approach, although intuitive, is provably biased and inconsistent because the method to weight each of the replicated observations is based on the marginal probability and does not properly account for the covariates. Stajduhar and Dalbelo-Basic (2012) adopt a more principled likelihood-based approach to imputing event times, but their imputation technique may perform poorly if the assumed parametric distribution of event times is incorrect. Other approaches, including replacing the time-to-event with the martingale from the null model, have been proposed to handle censored data in other machine learning methods including support vector regression, recursive partitioning, and multiple adaptive regression splines (Therneau et al. 1990; Kattan et al. 1998; Kattan 2003) . However, these approaches require that the technique to mine the data permit a continuous outcome and are, therefore, not amenable to the Bayesian network approach considered here.
In this paper, we develop an extension of Bayesian networks which accounts for right-censored event indicators using inverse probability of censoring weights (IPCW) (Robins and Finkelstein 2000; Tsiatis 2000, 2002; Rotnitzky and Robins 2004; Tsiatis 2006) . We begin by reviewing a classical Bayesian network approach, operating on a binary indicator of whether or not each subject experienced an event during the follow-up period. Clinical knowledge is used to construct a graphical model relating the relevant risk factors to the probability of an event. We then describe a model-averaging strategy to control model complexity and stabilize risk predictions for small patient subgroups. The application of IPCW to handle censored outcomes in Bayesian networks is discussed before we describe how to extend traditional predictive performance evaluation metrics for the censored outcome setting.
Bayesian networks
Let the features recorded on a patient be represented by a p-dimensional vector X = (X 1 , . . . , X p ) where X i is the ith risk factor (values for some of the factors could be missing for certain patients). Let E = 1 indicate that an event (e.g., a CV event) occurred for a given patient within τ years of the beginning of the follow-up period, and E = 0 indicate the absence of such an event in that time frame. Though our ultimate goal is to handle the case where E is unknown for some patients, for now we assume that at least τ years of follow-up is available on each patient so that E is fully observed.
The target of estimation is P E|X (e|x), the conditional probability that E = e given the features x of a particular patient. Using Bayes theorem, one can rewrite this conditional probability of an event as
so that the focus is shifted to estimation of the conditional density/probability P X|E (x|e) and the probability P E (e) for e = 0, 1. To maintain notational brevity, we use P Y (y) to denote either the probability that the random variable Y equals y if Y is discrete or the probability density of Y evaluated at y if Y is a continuous random variable. Similarly, P Y |Z (y|z) is the conditional probability/density of the random variable Y evaluated at y given Z = z. In general, the dimensionality of the feature space p may be too large to make joint modeling of P X|E (x|e = 1) feasible. To simplify the joint modeling task, one can represent the joint distributions of X|E = e using a directed acyclic graph (DAG), i.e., a Bayesian network. The DAG encodes conditional independence relationships between variables, allowing the joint distribution to be decomposed into a product of individual terms conditioned on their parent variables (Stuart and Peter 2003) :
where Pa(X i ) are the parents of X i . One advantage of the Bayesian network approach is that clinical knowledge can be used to suggest and refine DAG structures. While methods exist to infer the DAG structure from data, in our application we used parsimonious DAGs based on information from the medical literature as well as clinical judgment from the medical experts who collaborated on this research project. The DAG structure used in our predictive models is shown in Fig. 1 (see the caption of the figure for a brief description) and is explained in greater detail in Sect. 3. The graphical model in Fig. 1 contains both continuousvalued nodes (which are elliptical in the figure) and discrete-valued nodes (which are rectangular). The network is, therefore, a hybrid Bayesian network (Murphy 1998 ).
Learning Bayesian network parameters
As noted above, to estimate P E|X (e = 1|x) we choose to develop models for P X|E (x|e) and P E (e). When E is observed on all subjects, the maximum likelihood estimate of P E (e) is straightforward:P
where E j is the CV event status for the jth person, n is the number of people in the training set, and I[·] is the indicator function.
To evaluate the joint distributions P X|E (x|e), for each feature X i (or group of features modeled jointly, such as the lipid measures in our DAG) we construct vectors G i , such that G i = {X i , Pa(X i )}, and learn the joint density P G i |E (g i |e) of each of the groups. The conditional density used in Eq. (2), P X i |Pa(X i ),E {x i |Pa(x i ), e}, can be The graphical model for our Bayesian network for CV risk prediction. The figure includes the structure of risk factors, conditioned on the CV event status. In particular, nodes represent input variables and edges represent conditional dependencies between the variables. The reader should also assume that our outcome variable (CV Event) is connected to every node in the graph (omitted in the picture for parsimony). Continuous and discrete variables are indicated by elliptical and rectangular nodes, respectively. Nodes in boxes with rounded corners indicate that they are modeled jointly. The nodes are grouped into subgraphs indicated by the dashed boxes. The grey edge between subgraphs indicates an edge from every node in the source subgraph to every node in the destination subgraph or node. The full description of each of the features appears in Sect. 3. Comorbidity Whether or not patient has pre-existing CVD or another comorbidity related to CVD; Smoke current smoking status of patient; BMI body mass index of patient; SBP systolic blood pressure; SBP Med Number of blood pressure medication classes currently prescribed to patient; TRG triglycerides; HDL high density lipoprotein; LDL low density lipoprotein (note that TRG, HDL, and LDL are components of a patient's cholesterol measurement and that HDL and TRG are modeled jointly); LDL Med indicator for whether the patient is on LDL lowering medication derived from these joint distributions, as described in Sect. 2.6. This approach differs slightly from the conventional strategy, where a regression model is constructed to link the values of the continuous parent nodes of X i to the mean of X i . Typically, we would assume that the mean of X i is linearly related to the values of the parent nodes and we must learn or estimate the parameters in this linear regression model. Our approach provides more modeling flexibility (because we do not have to specify a regression model) without a substantial increase in computation due to our DAG structure, where continuous nodes are arranged in relatively small, mutually independent groupings.
The components in
where P Z i |E (z i |e) is simply a discrete probability distribution. We can easily estimate this distribution by computing the proportion of observations in each unique state of Z i separately for E = 0 or E = 1, which is the (non-parametric) maximum likelihood estimator of this discrete distribution. That is,
where again j indexes the subject.
For the continuous components, we model the conditional density of Y i given Z i and E as a mixture of M multivariate normal densities conditional on the levels of Z i and E:
where φ k (·) is the density function of a k-variate standard normal random variable, μ i,m,z i ,e and Σ i,m,z i ,e are the mean and variance matrix of Y i given Z i = z i and E = e for the mth multivariate normal density in the mixture, and ρ i,m,z i ,e are the mixing parameters where M m=1 ρ i,m,z i ,e = 1. Here we allow μ i,m,z i ,e and Σ i,m,z i ,e to differ for different levels of Z i and E. These parameters are estimated using the expectation maximization (EM) algorithm to solve for the maximum likelihood estimates. If each
For a fixed number of mixing components M and given E = e and Z i = z i , a standard EM algorithm (Dempster et al. 1977 ) is used to solve for the maximum likelihood estimators of the mean, variance, and mixing parameters. The mixing indicators I i,m,z i ,e (m = 1, . . . , M) are viewed as missing data with probabilities/expectations ρ i,m,z i ,e . We note that the complete data log-likelihood for the model of
where θ is the unique parameters of μ i,m,z i ,e , Σ i,m,z i ,e , and ρ i,m,z i ,e , for m = 1, . . . , M.
For a current iteration of the parameter estimate θ (ν) , we can (i) take the expectation of the complete data log-likelihood given the observed data assuming that θ (ν) is the true value of the parameter (E-step), and then (ii) maximize the conditional expectation with respect to θ (M-step) to obtain θ (ν+1) . In this well-studied Gaussian mixture problem, it is possible to derive explicit update formulas for both mixing and distributional parameters so that the "E-step" and "M-step" are performed simultaneously. In particular,
Additional details of the algorithm can be found in Bilmes (1998) .
The preceding discussion has assumed a fixed M. To control overfitting, one could consider M to be a tunable parameter and select the number of mixture components using the Bayes information criteria (BIC) or some other goodness-of-fit measure. Alternatively, in the following section, we describe a model averaging procedure to combine results across multiple values of M.
Model averaging
Increasing the number of mixture components M in our models can lead to overfitting. This is even more likely when we try to model distributions that are represented by small subgroups of patients. For example, in our proposed Bayesian network (see Fig. 1 ), we must estimate the conditional distribution of age given CV event status, comorbidity status, and gender. However, the number of females with pre-existing conditions and experiencing a CV event is small relative to the size of the cohort; therefore, a highly flexible model for the conditional age distribution may lead to unreliable estimates of this distribution. We propose to reduce overfitting by implementing a model averaging approach using a weighted average of conditional probability densities from models with varying number of mixing parameters. The weights are derived from the BIC, which penalizes model complexity and is an approximation to the posterior probability of the model (Jackson et al. 2009 ). Although model averaging has been used to average over different network structures in Bayesian networks (Tian et al. 2010) , to the best of our knowledge it has not been previously used to average over models of varying complexity within a single network structure.
To implement the model averaging, we take T = 40 bootstrap samples from our training data. For each bootstrap sample, we fit models as described in Sect. 2.3 with M = 1, . . . , Q mixture components. That is, for a given bootstrap sample t and number of mixture components M, we estimate the parameters from Eq. (6) using the standard EM algorithm described above. The weights w (M) i,z i ,e for each level of model complexity M for modeling the conditional distribution Y i given Z i = z i and E = e are computed as follows:
where B
i,z i ,e, j is the BIC of the model for the conditional distribution Y i given Z i = z i and E = e fit on the jth bootstrap sample with M mixtures. The BIC is computed as −2 log(L) + k log(n) where L is the log-likelihood evaluated at the maximum likelihood parameter estimates, n is the number of subjects included in the training set, and k the number of (free) parameters included in the model.
The probability density of an ensemble is estimated by finding the weighted mean of the probability of each mixture model in the ensemble. For example,
whereΨ t i,m,z i ,e is the summand of Eq. (6) with parameters estimated from bootstrap sample t. Generally, the maximum number of mixing parameters Q should be large enough so that the largest values of M (M = 1, . . . , Q) do not receive high weight w (M) i,z i ,e . In our real data analysis of CV risk, we take Q = 4.
Extension to censored time-to-event data
Our development thus far has assumed that the presence or absence of a CV event E is fully observed for all patients in the data set, but this is unlikely to be true when using information from real-world EHD. In our application, once a patient leaves the health system or the study ends, their health state (i.e., features of the risk prediction model) and event history are no longer recorded in the EMR. If the patient's follow-up ends prior to τ , then their event status at τ is unknown and their event indicator is said to be right-censored. In this section, we show how it is possible to use a Bayesian network to predict the risk of a CV event in τ years when the event status at τ years is rightcensored. To establish notation (which is standard in the statistical literature), define T as the time between the beginning of the follow-up period and a CVD event, and define C as the time between the beginning of the follow-up period and disenrollment or the end of the data capture period. We observe V = min(T, C) and δ = I(T < C), the indicator for whether or not a CV event occurs. If δ = 0, the subject's event time is right-censored. We can only ascertain the value of E either if δ = 1, or if δ = 0 and V > τ; in other words, the value of E is only known if min(T, τ ) < C.
As mentioned earlier, one naive approach to handling the subjects for whom we cannot ascertain the value of E would be to exclude them from our training data set or to set E = 0, but both approaches would lead to biased estimators of the CV risk. Instead, we propose to adjust for right-censoring using an inverse probability of censoring weighting (IPCW) approach. This approach to handling censored event times assumes that the censoring time C is independent of the CV event time T and all features X. In our study, most patients are censored due to the end of the study or because they disenroll from the HMO due to a change in employment, reasons unrelated to their health status (i.e., X and T ). Let G(t) = P(C > t) be the probability that the censoring time is greater than t. We can estimate G(t) = P(C > t), using the Kaplan-Meier estimator of the survival distribution (i.e., 1 minus the cumulative distribution function) of the censoring times. The Kaplan-Meier estimator (Kalbfleisch and Prentice 2002) of the censoring process is given bŷ
where d * i is the number of subjects who were censored at time t i , and n i is the number of subjects "at risk" for censoring (i.e., not previously censored or experiencing a CV event) at time t i . Unlike other ad hoc approaches to handling censored observations, the Kaplan-Meier estimator is a consistent estimator of G (Kalbfleisch and Prentice 2002) . We note that, for IPCW, Kaplan-Meier is applied to estimate the distribution of censoring times, whereas it is much more commonly used to estimate the distribution of event times. Standard software functions for computing the Kaplan-Meier estimator of events times can be used to estimate G by setting the "event" indicators to δ * i = 1 − δ i . Having computedĜ, for each patient j we define a inverse probability of censoring weight (IPCW):
To fit the Bayesian network using IPCW, estimation of the parameters in P E (e) and P G i |E (g i , |e) is carried out using weighted maximum likelihood, where the contribution of the jth subject to the likelihood is weighted by ω j . In particular, Eqs. (3) and (5) becomeP
respectively. One can show that the IPCW estimator of P E (e = 1) is the Kaplan-Meier event probability (i.e., the Kaplan-Meier estimator is an IPCW estimator).
To estimate the parameters in P Y i |Z i ,E ( y i |z i , e) we use a weighted EM algorithm where the contribution of each subject j is weighted by ω j . In particular, the complete data log-likelihood for the EM algorithm becomes
The update formulas for the parameter estimates previously given in Eq. (8) now become
, as before. Further details of the weighted EM algorithm are provided in Fraley et al. (2012) . In the case that we use model averaging with bootstrap subsamples rather than a fixed model complexity, the weights are computed on the full training sample, and are not reestimated for each bootstrap sample. Many software packages implementing the EM algorithm (e.g., Matlab, R) allow weights to be provided as arguments to the EM function, making the IPCW Bayesian network approach straightforward to implement.
In the IPCW approach, only those patients for whom we can determine E contribute to the analysis, but they are reweighted to accurately "represent" the patients who were censored prior to τ and were, therefore, omitted from the analysis. For example, patients that have a longer time to event are more likely to be censored (G is smaller) and, hence, receive larger weights. Note that for subjects with E = 0 (and V > τ) the weights for all individuals are 1/Ĝ(τ ), so the maximum likelihood estimators for P G i |E (g i |e = 0) are the same as in the unweighted analysis.
We briefly discuss why inverse probability of censoring weighting results in consistent estimators (i.e., unbiased in large samples and converging in probability to the true parameter) for the parameters in the Bayesian network using an illustrative example. In particular, if we fully observed the event status E on all subjects and wished to estimate μ i,z i ,e , a reasonable estimator would be the sample average of Y i among all subjects in the training set with Z i = z i and E = e:
When E is not observed on all subjects, an IPCW estimator is given bŷ
Combining this fact with the assumption that C is independent of T and X, it can be shown that the numerator and denominator in Eq. (18) converge in probability to the same quantity as in the non-IPCW case, so thatμ I PCW i,z i ,e converges in proability to μ i,z i ,e . The reader is encouraged to consult the cited references above, especially Bang and Tsiatis (2000) , for a rigorous theoretical treatment. The IPCW parameter estimators and parameter updates in the EM algorithm, i.e., Eqs. (13), (14), and (16), take the form of weighted sample averages. Therefore, the results of the illustrative example considered here are generalizeable to all IPCW estimators.
Obtaining predictions
To obtain the prediction P E|X (e = 1|x), we need to evaluate the right-hand side of Eq. (1), where P X|E (x|e) is given by the product in Eq. (2) resulting in:
As noted above, the joint modeling described in Sect. 2.3 yields conditional distributions via the expression
Estimates for P
, which we discussed in the preceding sections, may be substituted in Eq. (20) to obtain an estimate for P X i |Pa(X i ),E (x i |Pa(x i ), e) which in turn may be substituted into Eq. (19) to obtain P E|X (e = 1|x).
Missing features
Within EHD, it is relatively common for attributes to be unmeasured on certain patients; for example, cholesterol measurements are available on only a small fraction of patients under the age of 40. One of the advantages of Bayesian networks is that we can still obtain predictions for subjects in the validation set with incomplete features; we can also use information on subjects in the training set to learn parameters in the Bayesian network without having to impute the missing covariate values. To obtain an estimate of P E|X (e = 1|x) if X i is missing, the corresponding product term from Eq. (1) is dropped. When any attribute from Pa(X i ) is missing (say A i ), we substitute
is estimated from subjects with A i observed and then derive the conditional probability from the joint distribution. In our data, information regarding medications, gender, smoking, and comorbidity is never missing; therefore, we are concerned only about marginalizing the continuous part of the joint distribution.
Summary of the modeling process
In the previous sections we provided a detailed discussion of the components of the proposed approach. To explain how all of these components fit together, Algorithm 1 provides a high-level overview of the entire modeling process.
Algorithm 1 High-level overview of the proposed approach Input: Graphical structure of the probabilistic relationships (edges) between input features (nodes) Training dataset (each record consists of input values, follow-up time, and an event indicator) Output:
Function for estimating conditional probability of the CV event given the input values 1: Estimate survival distribution of the censoring times using Kaplan-Meier estimator // Equation (11) 2: For each subject (each record in a dataset): 3: Compute the inverse probability of censoring weight using the distribution from Line 1 // Equation (12) 4: For each node X i in the graphical model: // Figure (1) 5: Identify the set of parent nodes of X i , i.e., Pa(X i ) 6: Model the conditional joint distribution of X i and Pa(X i ) given event status as follows: 7:
Partition G i into continuous and discrete features 9:
For the set of discrete features of G i : 10:
Compute the IPCW estimates of the conditional probability given event status using the IPCW weights from Line 3 // Equation (14) 11:
For the set of continuous features of G i : 12:
For each distinct state of discrete features of G i and event status: 13:
For each number of multivariate Gaussian mixtures (vary from 1 to 4): 14:
Create 40 Obtain conditional joint distribution of G i given event status by multiplying discrete probability estimates from Line 10 and conditional density of continuous features from Line 20 // Equation (4) 22: Derive conditional distribution of node X i given parents Pa(X i ) and event status using the conditional joint distribution of G i from Line 21 // Equation (20) 
where T is the number of bootstrap samples, Q is the maximum number of mixtures that we try to fit, S G i is the number of possible discrete states in the set of variables G i , |X| is the number of variables in the graphical network, and R is the worst-case time-complexity of the EM algorithm. T and Q are tuning parameters which do not depend on sample size. Under the assumption that a fixed constant number of iterations will be sufficient for the convergence of EM algorithm (a common assumption in many EM software implementations), R is linear in the sample size in our case. S G i and |X| are determined by the network structure, which in our case is fixed in advance. Hence, these terms do not depend on sample size but may dominate the complexity; in particular, S G i is the product of the number of different states for each discrete variable appearing in the joint distribution. The graphical model used in this paper involves a fairly small number of discrete features (gender, comorbidity, blood pressure medications, LDL medications, and smoking) each with a relatively small number of states, and max i S G i = 16.
In terms of practical runtime considerations, an implementation of this algorithm using Matlab on a standard desktop machine required approximately 25 min to train the model on a dataset comprised of around 130,000 records. Obtaining the predictions of approximately 42,000 records required around 10 s. This further demonstrates the ability of the proposed approach to scale to large real-world healthcare applications.
The proposed method takes several steps to ensure stability. In general, the stability of the EM algorithm used to compute the model parameters depends on the data. There could be scenarios where the size of the training set is insufficient to learn the parameters using the EM algorithm for certain combinations of discrete features. We circumvent this problem by dynamically adjusting the number of multivariate Gaussian mixtures that we use to learn the distribution using model averaging. That way, more complex models which may have difficulty converging in small training sets and are likely to overfit the data receive little weight in the model averaging. In addition, the bootstraping component of the model averaging technique minimizes the effect of the EM not converging (within the fixed number of iterations) for some of the samples.
Performance evaluation metrics for censored data
The challenge of machine learning for censored data extends beyond improving existing methods to handle censoring. As we discuss in this section, the usual performance metrics applied to classification and prediction problems can be misleading when outcomes are subject to censoring. Here we present generalizations of standard calibration (goodness-of-fit test statistic) and discrimination (concordance index and net reclassification improvement) metrics which properly account for censored data and allow model performance to be assessed more accurately. For the statistics described in this section, closed-form expressions for the asymptotic variance are usually not available, and hence standard errors for the calculation of confidence intervals and p values are obtained by bootstrap resampling.
Calibration
For standard binary classification problems, calibration is commonly assessed by ranking the predicted class probabilities for the test set, binning the ranked predictions (e.g., by decile), and comparing the mean (or median) predicted class probability in each bin to the empirical class probability of the instances in that bin. We adopt a similar approach here, except that the empirical probability of experiencing an event prior to time τ within each bin is computed via the Kaplan-Meier estimator to properly account for censoring. Calibration plots compare predicted and Kaplan-Meier probabilities of experiencing an event before τ within bins defined by ranges of predicted probabilities. We compute the calibration statistic
where B is the number of bins,p j is the average of predicted probabilities in bin j, p K M j is the Kaplan-Meier estimate of experiencing an event before τ, S j (τ ) is its corresponding survival rate (= 1 − p K M j ), var( p K M j ) is its variance calculated using Greenwood's formula (Greenwood et al. 1926) applied to the data in bin j, d i j is the number of events occurring at time t i in bin j, and n i j are the number of people "at risk" for an event at time t i (i.e., not censored and not experiencing an event before time t i ). K is analogous to the χ 2 statistic for assessing the calibration of logistic models suggested by Hosmer and Lemeshow (1980) , Lemeshow and Hosmer (1982) .
Concordance index
The area under the ROC curve (AUC) is a widely used summary measure of predictive model performance. However, for the same reasons that standard classification techniques fail on censored outcomes, the AUC can also be misleading. Hence, we employ a generalization of the AUC, the concordance index (C-index) for censored data.
As described in Harrell (2001) , the C-index adapted for censoring considers the concordance of survival outcomes versus predicted survival probability among pairs of subjects whose survival outcomes can be ordered, i.e., among pairs where both subjects are observed to experience a CV event, or one subject is observed to experience a CV event before the other subject is censored. Pairs in which both subjects are censored or in which the censoring time of one precedes the failure of the other do not contribute to this metric. LetP E j |X j (e j = 1|x j ) be the estimated probability that the jth subject experiences an event within τ years. Then the C-index adapted for censoring is given by
Note that the only pairs which contribute to C cens (τ ) are those where one subject experiences an event prior to τ and the other is known not to have experienced an event before the first subject. In the absence of censoring, the C-index and AUC coincide.
Net reclassification improvement
The C-index may be inadequate to distinguish between models that differ in relatively modest but clinically important ways . Therefore, in addition to the C-index, we also evaluate the performance of our models using the Net reclassification improvement (NRI) metric , which allows the incorporation of relevant domain knowledge into the performance evaluation process. As with the other metrics presented in this section, the NRI must be adapted to handle censored outcomes.
The NRI compares the number of "wins" for two models among discordant predictions. It has been argued that NRI is a particularly relevant measure of comparison between models in the clinical domain, where it is often more important to discriminate between lower and higher risk patients than to estimate their risk precisely. Briefly, the NRI is computed by cross-tabulating predictions from two different models with table cells defined by clinically meaningful CV risk categories or bins, then comparing the agreement of discordant predictions with actual event status. Formally, the NRI for comparing prediction models M 1 and M 2 using fully observed (i.e., not censored) binary event data is given by:
Here E ↑ M 1 is the number of individuals who experienced events and were placed in a higher risk category by M 1 than M 2 (i.e., a number of "wins" for M 1 over M 2 among patients who had events), and the opposite change in risk categorization yields E ↑ M 2 ). Similarly,Ē ↓ M 1 andĒ ↓ M 2 count the number of individuals who did not experience an event and were "down-classified" by M 1 and M 2 , respectively (i.e., "wins" among patients who did not have events). Also, n E and nĒ are the total number of patients with events and non-events, respectively. A positive NRI(M 1 , M 2 ) means better reclassification performance for M 1 , while a negative NRI(M 1 , M 2 ) favors M 2 . While NRIs can theoretically range from −1 to 1, in the risk prediction setting they do not typically exceed the range of −0.25 to 0.25. For example, Cook and Ridker (2009) calculated the effects of omitting various risk factors from the Reynolds Risk Score model for prediction of 10-year CV risk. The estimated NRIs ranged from −0.195 (omitting age) to −0.032 (omitting total cholesterol or parental history of MI), and all were statistically significant at the 0.05 level. In our application, we defined three risk strata based on clinically relevant cutoffs for the risk of experiencing a CV event within 5 years: 0-5 % (low risk), 5-10 % (moderate risk), and >10 % (high risk); risk predictions for an individual were considered discordant between two models if the predictions fell in different ranges.
The predictions that are reclassified from one risk category to another can be represented in two tables, one for people having events (Table 1b ) and one without (Table 1a) , where the risk has been categorized into 3 levels: "high", "medium", and "low" using the aforementioned risk cutoffs. The entry in Table 1a , N n i j , represents the number of people without events who were classified as belonging to risk category Table 1b , N e i j , represents the number of people with events who were classified as belonging to risk category i by model M 2 that were reclassified as belonging to risk category j by model M 1 . For a person with events, a "win" for model M 1 over M 2 means M 1 predicts a higher risk category for the person than M 2 . Based on our reclassification table, E ↑ M 1 = N e mh + N e lh + N e lm . Similarly, the number of "wins" M 2 has over M 1 for people with events is: E ↑ M 2 = N e hm + N e hl + N e ml . For people without events, we can write the write the corresponding "wins" from Table 1a as follows:Ē ↓ M 1 = N n hm +N n hl +N n ml andĒ ↓ M 2 = N n mh + N n lh + N n lm . n E and nĒ are the sum of the entries in Table 1b and a respectively. From the values obtained using the reclassification tables, the Net reclassification improvement is evaluated using Eq. (24).
The NRI statistic cannot be applied directly to data where the outcome status of some subjects is unknown. In our setting, omitting subjects with <5 years of followup (or treating them as non-events) will result in biased estimates of the NRI. To evaluate risk reclassification on our test data which are subject to censoring, we use a "censoring-adjusted" NRI (cNRI) due to Pencina et al. (2011) which takes the form:
Electronic health data and preprocessing
Our study was conducted utilizing the HMO Research Network Virtual Data Warehouse (HMORN VDW) from a healthcare system from the Midwestern United States. The VDW stores data in standardized data structures including insurance enrollment, demographics, pharmaceutical dispensing, utilization, vital signs, laboratory, census and death records. These data are obtained from both the EMR and insurance claims. This health care system includes both an insurance plan and a medical care network in an open system which is partially overlapping. That is, patients of the insurance plan may be served by either the internal medical care network and or by external healthcare providers, and the medical care network serves patients within and outside of the insurance plan. Patient-members who do not visit any of the clinics and hospitals in-network do not have any medical information (e.g., blood pressure information) included in the EMR of this system. Furthermore, once the patient-member disenrolls from the HMO, the patient no longer has any information recorded in the EMR or insurance claims data.
The study population was initially selected from those enrolled in the insurance plan between 1999 and 2011 and who had at least one outpatient medical encounter at an "in-network" clinic. This initial selection identified 448,306 subjects.
The goal of our analysis is to develop accurate prediction models of CV risk for patients seen in the primary care clinics of the HMO. Such models will help inform physicians and patients of appropriate courses of action to take in order to reduce the patient's likelihood of experiencing a CV event.
In many epidemiological cohorts, patients are screened at a single or small number of visits, where measurements on all risk factors are collected, and then followed from the final screening visit to determine if and when they experienced a CV event. However, in clinical practice, patients may have relevant risk factors recorded over a series of visits to the physician. Therefore, we divided the EHD on any given patientmember into: (i) a baseline period, where we ascertained the risk factors, and (ii) a follow-up period, where we assessed whether a patient experienced a CV event (and, if so, when) . The baseline period consisted of the time between the first blood pressure reading during the enrollment period and the date of the final blood pressure reading at most 1.5 years from the first measurement. This approach balances the competing goals of having a long baseline period so that we capture data on as many features as possible and a long follow-up period to reduce censoring.
The follow-up period for a patient begins at the end of the baseline period and continues until either the patient experiences a CV event (defined below), or the patient disenrolls from the HMO for more than 90 days, or the study ends (2011), whichever comes first.
Inclusion and exclusion criteria
To ensure that we had sufficient time to collect baseline risk factors on subjects, we restricted the analysis to those subjects with at least 1 year of continuous insurance enrollment. Some of the patients were sporadically enrolled during the period of study; however, for the purpose of our analysis, we ignored gaps in enrollment <90 days and considered a patient-member continuously enrolled over this period (these gaps in enrollment are likely due to administrative errors or patients changing employers but still electing coverage with the same HMO).
We further restrict our study population to include only patients with two medical encounters in the in-network clinic with blood pressure information at least 30 days but at most 1.5 years apart, with drug coverage, and greater than 18 years of age at the end of the baseline period. These inclusion criteria were implemented because we wanted to predict CV risk among those patients treated routinely in the primary care clinic. Patients who are only infrequently treated in the emergency room or urgent care clinics (i.e., settings where patients are unlikely to be counselled about their CV risk) were not of interest in this analysis.
Finally, in this study we included only non-diabetic patients. Diabetic patients represent a highly specialized population and would benefit from a specialized risk prediction model that is targeted specifically to them, such as the UKPDS model (Clarke et al. 2004) , which was beyond the scope for this specific paper. The inclusion and exclusion criteria are summarized in Fig. 2 , and the distribution of the follow-up periods for the resulting analysis cohort is given in Fig. 3 .
Risk factor ascertainment
Risk factors incorporated in the Bayesian network include age, gender, systolic blood pressure (SBP), smoking status, body mass index (BMI), cholesterol-related measurement values (LDL, HDL, TRG), blood pressure and cholesterol medications, as well as indicators of pre-existing CVD and other diseases related to CV events (i.e., preexisting related diagnoses or procedures). The summary statistics for the risk factors are given in Table 2 . We also provide a brief discussion on how each of the features and the outcome, CV event, was defined based on information in the EMR and claims data.
Systolic blood pressure (SBP)
Calculated as an average of all the blood pressure measurements taken during the baseline period. Blood pressure readings obtained during emergency department visits, urgent care visits, hospital admission, and during procedures (e.g., surgeries) were excluded from consideration because they may be influenced by acute conditions.
Body mass index (BMI)
Calculated as a function of patient's height and weight. The height of an individual is the average height measured at any encounter (possibly outside of the baseline period). Because all subjects in the analysis dataset are over 18 years of age, we expect height to remain relatively constant over the follow-up period. The weight is calculated as an average of all weight measurements taken during the baseline period.
Initial cohort (n=448,306).
Included patients-members: a) Enrolled between 1999-2011 AND b) At least one visit to in-network clinic or hospital
Exclude 87,557 patients with continuous enrollment less than one year.
Exclude 168,841 patients without two blood pressure measurements at least 30 days and at most 1.5 years apart. Final analysis cohort (n=168,822).
Fig. 2 Flowchart of inclusion and exclusion criteria for analysis
Low density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides (TRG)
The most recent laboratory measurements before the end of the baseline period is used for these lipid measures including low density lipoprotein, high density lipoprotein, and triglycerides.
Smoking status
Information about smoking is complicated by the fact that many individual's responses vary considerably over time. In our dataset, there are four categories of smoking history, never smoked, smoking, quit smoking, and passive (i.e., second-hand) smoking. In our analysis, a person is considered to have never smoked only if they consistently recorded "no smoking" throughout their association with the insurance provider. A person who Distribution of patient follow-up times, i.e., time from the end of the baseline period until the patient experiences a CV event, the patient disenrolls from the HMO for more than 90 days, or the study ends, in our entire cohort after applying inclusion and exclusion criteria has recorded at least two "smoking" responses is considered currently smoking. For the purpose of constructing the model we combine the "passive smoking" and "no smoking" categories.
SBP and LDL medications
In our model, SBP medications are represented as the number of different medication categories a person is prescribed at the end of the baseline period. In particular, SBP medication categories included: alpha-blockers, beta-blockers, calcium-blockers, ace-inhibitors, angiotensin, vasodialator, and diuretics. LDL medication represents an indicator for whether or not a patient is taking any LDL lowering medications, such as statins and fibrates, at the end of the baseline period. For our analysis, we ignore information regarding the specific drug dosages because it is difficult to make comparisons between doses from different variants of the same drug.
Comorbidities
Comorbidities represent serious pre-existing conditions (diseases) and previously occurred CV events or procedures (surgeries). The existence of comorbidities significantly elevate the risk of having a CV event in the future. In our study, we included the presence of any of the following diagnoses (including a diagnosis of a "history of these conditions) at any point before the end of the baseline period: chronic kidney disease, coronary heart disease, CVD, peripheral artery disease, atrial fibrillation, congestive heart failure, myocardial infarction (MI), and stroke. As we discuss below, the diagnosis may be part of the EMR or contained as part of an insurance claim. The Bayesian model that we consider treats comorbidities as a binary variable. 
CV Event (outcome variable)
Events are the first recorded stroke, myocardial infarction (MI), or procedure proximal to stroke or MI (e.g., coronary artery bypass surgery, stent for either the coronary arteries or carotid artery) after the baseline period. This information is obtained from diagnosis codes recorded by physicians or inferred from procedures (such as bypass surgery or stent placement) performed on an individual. In addition to using procedure and diagnosis codes to infer if a CV event occurred, we consider a patient to have experienced a CV event if the cause of death listed on the death certificate included MI or stroke.
We note that the diagnosis and procedure codes used to define CV events and comorbidities may be part of the EMR or part of claims data (to justify the insurance claim). The implication of this is that patients do not have to seek care at an in-network hospital following a CV event to infer that the patient had a CV event. The total number of first CV events recorded within the follow-up period is 5,410; the Kaplan-Meier 5-year event rate for the entire analysis cohort is 4.53 %.
3.3 Determining the structure of the Bayesian network Figure 1 displays the structure of the Bayesian network that we used to construct our prediction models. The structure was determined by combining known relationships from the medical literature with input from our clinical colleagues. For example, SBP is known to depend on age, BMI, and the number of blood pressure medication classes prescribed (Rockwood and Howlett 2011) ; therefore, age, BMI, and blood pressure medication nodes are represented as parents of SBP nodes in the DAG. People with higher BMI are known to have higher LDL, triglycerides (TRG) and lower HDL (Lamon-Fava et al. 1996) . In addition, lipid medications (statins) reduce LDL levels (Law et al. 2003) . Therefore, in this case, BMI is represented as parent of LDL, HDL, and triglycerides; also, LDL medication is a parent of LDL. Moreover, smoking incidence in the United States is known to vary as a function of age (Agaku et al. 2011) ; therefore, age is represented as a parent of smoking.
In some cases, it may be preferable to consider several network structures reflecting plausible relationships between predictor variables. In the process of developing our approach, we considered several candidate network structures; within a set of similar candidates, the particular structure did not have a large impact on prediction performance.
Models and evaluation metrics
Our goal is to build risk models from EHD and, in the process, address issues typically encountered with EHD, such as right-censored outcomes, non-linear and nonmonotonic effects of risk factors on the risk of events, and overfitting in subgroups that are represented by relatively few patients. In the context of estimating the 5-year risk of a CV event using the data described in Sect. 3, we sought to compare our approach which trains the Bayesian network in Fig. 1 using inverse probability of censoring (Sect. 2.5) and using model averaging (Sect. 2.4) to other more traditional Bayesian network approaches as well as other techniques for modeling censored outcomes. Our approach, which we refer to as Bayes-AC (as it includes both model averaging and censoring weights), allows for non-linear relationships between the risk factors and outcome, addresses censored outcomes, and protects against overfitting in small subpopulations. In addition to our main approach, we also considered more basic Bayesian models using a single multivariate normal distribution (Bayes-1C) and a mixture of three multivariate normal densities (Bayes-3C) to model P Y i |Z i ,E ( y i |z i , e), i.e., no model averaging, but still accounting for censored outcomes.
For comparison, we also train the Bayesian network using an ad hoc approach for censored observations in which we excluded patients who did not experience an event and did not have 5-years of follow-up. This ad hoc approach to censoring was used both when the number of mixture components was fixed (Bayes-1 and Bayes-3) and with model averaging (Bayes-A) .
In addition to the different variations of the Bayesian network models, we considered a Cox proportional hazards model (COX) because this model is well-known in the medical community and well-suited to work with censored data. A drawback of the proportional hazards model is that it does not automatically allow for non-linear relationships between the risk factors and the log hazard. We chose to parameterize the proportional hazards model using the same parameters as was included in the Framingham risk model ). However, D'Agostino et al. (2008 do not include patients with prior comorbidities in the training set, so we include an indicator variable for comorbidity status. Additionally, the Framingham model includes an interaction between the log of SBP and blood pressure medication but does not include a main effect for blood pressure medication. We have included the blood pressure main effect in the model. One of the limitations in using the Cox proportional hazards model is that it requires complete predictor data to fit the model and to predict risks; therefore, we have to impute the missing data. We construct linear regression models stratified by gender and comorbidity with higher order terms (squared and cubic terms of the independent variables) to impute the missing data. In our case, age and SBP (which are known for all patients) are used to construct such a linear regression model for imputing BMI. Age, SBP, and the imputed BMI are in turn used to construct three different models for imputing LDL, HDL, and triglycerides, respectively.
For completeness, we also considered a regression-based approach which does not account for censored outcomes. Specifically, we considered a logistic regression model of the 5-year CV event status with all the same predictors as the Cox proportional hazards model described above. The same imputation method was used for missing features as described above. However, following the approach used for the Bayes-1, Bayes-3, and Bayes-A models, we excluded patients from the training set who did not experience an event and did not have 5-years of follow-up.
Finally, given the relatively large cohort size, we wanted to investigate whether we could achieve adequate performance using a subset of patients with only complete features and, therefore, avoid employing sophisticated data imputation techniques. We considered training the Bayes-AC and COX models using only subjects with all covariates measured (i.e., subjects with non-missing data), which we refer to as the Bayes-AC-NM and COX-NM models.
Brief descriptions of the models that we have used in our analysis are given in Table 3 . The training dataset consisting of 129,428 patients (75 % of the entire analysis population) was drawn at random from the cohort. However, as noted above, some of the modeling approaches use only a subset of this training dataset. In particular, those models which exclude patients who did not experience a CV event and did not have 5-years of follow-up were trained on 48,300 subjects. Those models which exclude patients that did not have complete data on all the features were trained on 42,523 subjects. The performance of all models is evaluated based on the risk predictions of the remaining 43,143 patients not included in any training set. The models are compared based on their calibration (as described in Sect. 2.9.1) and discrimination metrics, i.e., the C-index and cNRI (as described in Sects. 2.9.2 and 2.9.3). In addition to the calibration and the discrimination metrics, we also plot the difference between average risk and observed risk across different groups of predicted risk. That is, the training set is partitioned into bins with predicted CV risk between 0-2. 5, 2.5-5, 5-7.5, 7.5-10, 10-15, 15-20 , and >20 %. These bins were based on clinically relevant risk categories suggested by our clinical collaborators (similar categories have been used in prior literature). The observed risk within each bin was computed using the Kaplan-Meier estimator. While the calibration statistic K helps us compare the models using a single numeric metric, these plots provide us with more information regarding the calibration of a model for different risk ranges and the direction of deviation (over-or under-prediction) of the model from the observed risk. A perfectly calibrated model would be indicated by a horizontal line at 0 in these plots.
Results
The calibration and discrimination of the models, evaluated on the hold-out test set, is summarized in Table 4 . Specific comparisons between our approach, which incorporated model averaging and IPCW to train a Bayesian network, and other more standard modeling approaches are described in detail below. The Bayesian network models that do not incorporate inverse probability of censoring weighting and the logistic regression model discard subjects who do not have a followup time of at least 5 years and do not experience an event, but still include subjects who have events even if they have a follow-up time of <5 years. As a result, all of these models (Bayes-1, Bayes-3, Bayes-A, and Logistic) over-predict risk and, hence, are poorly calibrated (see Table 4 ; Fig. 4 ). Although the observed 5-year event rate for the test set was 4.53 %, the average risk predicted by Bayes-1, Bayes-3, Bayes-A, and Logistic was 6.05, 6.05, 6.29, and 6.87 %, respectively. While the censoring-unaware Bayesian network models are poorly calibrated, their discrimination capability (0.8843, 0.8790, and 0.8835) is at least as high as that of the COX model (0.8795) and statistically significantly higher than that of the logistic regression model (0.8752). The higher discrimination of the Bayesian network models compared to the regression model can be attributed to the fact that these models can capture dependencies and correlations between risk factors (such as SBP and age) and can fit the nonlinearities in the data better than the regression models without higher order terms and interaction effects.
We note briefly that, while these models show a significant improvement in the discrimination compared to the standard Cox proportional hazards models using cNRI, it is well known that the NRI statistic can be misleading when one of the models is badly calibrated, such as the models that do not account for censoring (Pepe 2011) . The cNRI statistic that we consider weights the percentage of "wins" for those experiencing an event equally to those not experiencing an event. The Bayesian network models that do not account for censoring are heavily biased toward predicting higher risk; Fig. 4 Calibration of Bayesian network models both with and without IPCW, COX, and logistic regression model on the hold-out test set therefore, it produces a significant number of "wins" for people who have events. Therefore, it is most meaningful to use the cNRI metric only when both models being compared are reasonably well-calibrated.
Bayesian networks with model averaging
The Bayes-3C model, in which all continuous features are modeled as a mixture of three multivariate normal distributions, consistently performs worse than the modeling approach with less flexibility (Bayes-1C) across all measures of calibration and discrimination. In contrast, considering a model-averaged estimate of CV risk, which averages over model complexity using a data-driven approach, led to significant improvement in both calibration and discrimination (see Fig. 5 ). Specifically, the averaged model (Bayes-AC) predicts the risk of a CV event better in groups where few events occur. For example, in the sub-population of patients that are not on blood pressure medications which has an event rate of only 0.81 % (as compared to an average event rate of 4.53 %), the Bayes-AC model has C-index of 0.81 which is significantly higher than the C-indices 0.78 and 0.77 for the Bayes-1C and Bayes-3C models, respectively. In summary, complex model strategies are able to extract more structure from the data but must be implemented intelligently. The benefit of model averaging is that it allows the analyst to consider more complex models, but these more complex models (with greater number of mixture components) are only given substantial weight in Eq. (9) if there is enough improvement in the model fit to justify models with more parameters. As mentioned earlier, we use the BIC as the metric to balance model complexity and parsimony.
Bayesian networks accounting for censoring using IPCW
Comparing the parsimonious Bayesian networks and model-averaged Bayesian networks that do and do not incorporate inverse probability of censoring weights (Bayes-1 vs. Bayes-1C and Bayes-A vs. Bayes-AC), there is a dramatic improvement in the calibration of those models which properly account for censoring ( Fig. 4) . In these models, the average predicted event rates 4.40 % (Bayes-1C) and 4.46 % (Bayes-AC) is much closer to the observed event rate in the test set than the equivalent models that are trained ignoring censoring, as shown in Table 4 . Their calibration statistic is also much closer to zero, the value we would expect for a perfectly calibrated model. Both Bayes-1C and Bayes-AC also show slightly improved discrimination compared to the respective models that do not account for censoring (C-index 0.8845 vs. 0.8843 and 0.8859 vs. 0.8835, respectively). Considering the cNRI, both of these models are significantly better in terms of discrimination than the standard Cox proportional hazards model but, unlike the Bayes-1 and Bayes-A models, do not sacrifice calibration to improve net reclassification.
Overall, the Bayes-AC model, which uses inverse probability of censoring weights and model averaging, results in the best performance of all our Bayesian network models. Unlike the Bayes-1 model (a more traditional Bayesian network model), our approach properly accounts for censoring leading to improved calibration and properly protects against over-fitting leading to improved discrimination.
Censoring-aware Bayesian networks versus traditional survival analysis
As noted previously, the Cox proportional hazards model (COX) is the standard approach for data in which the outcome may be right-censored. As compared to this model, our Bayesian network model (Bayes-AC) provides improvement across all calibration and discrimination metrics considered for this predictive task. Overall, the calibration statistic for the Bayes-AC model (3.84) was much closer to 0, (i.e., the statistic for a perfectly calibrated model) in the test set than the one demonstrated by COX (11.66). The C-index of Bayes-AC is 0.8859 (vs. 0.8795 for COX), and the cNRI of Bayes-AC compared to COX is 5.88 %, both of which reflect significant improvement in the discrimination. To put the reclassification performance in context, this is more than the improvement that can be obtained from adding the total cholesterol into the COX risk prediction model (Cook and Ridker 2009 ). Our improvement in cNRI can be attributed to the fact that the Bayes-AC model classifies substantially more people with events into a higher risk category (Table 5b , Table 6 ) as well as larger number of people without events into a lower risk category (Table 5a , Table 6 ) than COX. Overall, Bayes-AC reclassifies a higher fraction of people in the correct direction. Although the overall improvement in calibration was not very large (Fig. 4) , the Bayesian network model allows for greater flexibility to model CV risk in certain subgroups. For example, it is generally understood that the CV risk rises with increased blood pressure (Stamler et al. 1993) . In most cases, our data supports this assertion. However for males who are already on a blood pressure medication, the relationship between the risk and blood pressure is not strictly increasing, as we see in Fig. 6 . The risk increases with decreasing SBP for SBP below 130 mmHg. This observation is interesting because physicians typically treat SBP down to 130 mmHg for people whose blood pressure is not controlled. Blood pressure being treated below 130 mmHg Fig. 6 Relationship between systolic blood pressure and CV risk for a subgroup of males between ages 40 and 55 who are on SBP medication may indicate an underlying disease which is probably evident to a physician but is not captured by the risk factors that we have trained our model on. The underlying disease increases the risk for this group of patients. The proportional hazards model that we are using forces a linear relationship between the log hazard and the log of SBP and, thus, ends up modeling the risk well only for people whose blood pressure is relatively elevated. This is evident in Fig. 6 which shows the Bayes-AC model with better fit with respect to the observed SBP and CV risk relationship. In addition, the C-index of the Bayes-AC model (0.611) is significantly higher than that of the COX model (0.517) for predictions in this subgroup.
Including patients with missing data
Of the 168,822 patients included in our study, 56,698 patients have observations for all the risk factors. Given that our model uses of only 11 risk factors, the number of people with complete observations should be enough to train the model; however, the missing covariates are not randomly distributed across all the patients in our cohort. As a result, excluding people who have missing data leads to biased estimation of the parameters in the model and poor calibration, as illustrated in Fig. 7 . For example, the mean age of our cohort is 44.7, while constructing a cohort of people with complete observations leads to a set with mean age of 52.9. As a result, the latter cohort has significantly higher risk than the general population. The missingness, in addition to being influenced by age, is also determined by physicians' decisions regarding the overall well-being of the patient. This implies that a cohort with complete observations is likely to be less healthy than the general population. In fact, after controlling for age and gender, the two most important risk factors, the 5-year CV event rate for the cohort with no missing data is significantly higher than for the general population. Males in the 40-45 years age group in the general population have a 5-year CV event rate of 1.94 %, while a similar group in the cohort with complete observations has a 5-year event rate of 2.85 %. Models constructed using the non-missing cohort (Bayes-AC-NM and COX-NM) under-predict the CV risk when applied to people who have part of their observations missing. For these patients, Bayes-AC-NM predicts an average 5-year risk of 3.29 % as compared to the observed 5-year risk of 3.80 %. However, as expected, for people who have complete observations, both the Bayes-AC-NM and COX-NM evaluate an average 5-year risk very close to the observed risk (Bayes-AC-NM: 5.82 %, COX-NM: 6.14 %, observed: 6.02 %). The miscalibration of the models is to be expected because the Bayes-AC-NM and COX-NM have no support for people with missing data and, as we have shown, these people are likely prognostically different from people with complete measurements.
Discussion
Summary and advantages of proposed method
This paper focuses on the application of a machine learning approach to risk prediction using EHD, when event times may be censored due to unequal individual follow-up. Traditional statistical models for event-time data with censored observations are welldeveloped, but typically less flexible than established machine learning techniques for classification. On the other hand, most classification techniques do not handle censoring, as they assume that labels in the training data are fully observed (or in the case of semi-supervised classifiers, observed on a random subsample of individuals). Our proposed technique combines features from both of these approaches, using inverse probability weighting to extend the Bayesian network technique for censored event data. Although we apply our approach to a Bayesian network, IPCW can be extended to other machine learning classifiers. Furthermore, we have implemented a novel model averaging approach to control the flexibility in the Bayesian network model. We have shown that the model averaging approach leads to improved prediction of CV events and allows us to extract more structure from the data without overfitting.
In addition to offering both modeling flexibility and statistical validity, our technique seamlessly handles missing data (which is common in EHD) and offers the opportunity to combine findings from the medical literature with clinical judgment to shape the model. The advantages of our method are illustrated by applying it to a large electronic health database. We show that: (1) ignoring censoring when performing classification results in grossly miscalibrated predictions, (2) the Bayesian network learns non-linear predictor-outcome relationships better than standard proportional hazards regression models of the type typically used to construct CV risk models from longitudinal studies with censored event data. We also emphasize the importance of using appropriate criteria for assessing the performance of predictive models for censored data. Commonly employed metrics for calibration and discrimination require event indicators that are fully known, and, therefore, can be misleading in the presence of censoring. We present alternate metrics which are tailored to the censored data setting.
Potential limitations of proposed method
As we noted previously, the use of inverse probability of censoring weighting relies on the assumption that the censoring time is independent of the CV event time. Heuristically, we assume that patients more likely to have a CV event are not more or less likely to disenroll from the health system. We could relax this assumption by modeling the censoring time as a function of the risk factors.
Though there are known techniques for searching across multiple DAG structures in the context of Bayesian networks, we chose to focus on techniques for learning parameters for a given, fixed network. This decision was motivated by the fact that our clinical collaborators desire model interpretability and face validity, which may not be achieved with an automated process determining network topology. Further, flexible methods such as Bayesian networks are prone to overfitting. We control overfitting in our method by implementing BIC model averaging and bootstrapping; in our experiments, the method was not highly sensitive to tuning parameter values which determined the maximum number of mixture components in each model and the number of bootstrap resamples, provided these were set within reasonable ranges (>3 and >10, respectively).
Generalizability and future work
Though motivated by an example in EHD, our technique is generally applicable to any situation where event outcomes are subject to censoring. For example, in economics, one might wish to predict whether recently unemployed individuals will be re-hired within a fixed time period, an outcome which is likely to be censored in most feasible study designs. In our context, we plan to incorporate this technique into a point-of-care clinical decision support system, which will provide more accurate CV risk predictions for patients based on their individual health history.
